Sigma-Genosys LP

1442 Lake Front Cir No. 185,
The Woodlands, Texas 77380-3608
United States,
(281)363-3693
www.genosys.com

Sigma-Genosys, a division of Sigma-Aldrich (NASDAQ:SIAL), sold its custom peptide and polyclonal antibody division to NEP, retaining its other product lines.

Sigma-Genosys was acquired by New England Peptide on October 19, 2017.

Join Mergr to view all 124 acquisitions of life science companies in 2008, including 20 acquisitions by private equity firms, and 104 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Sigma-Genosys.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.